CUREVO, INC.

Profile

Company Names

CUREVO, INC.

Addresses

18911 NORTH CREEK PKWY, SUITE 150, BOTHELL, WA 98011

21540 30TH DRIVE SOUTHEAST, SUITE 260, BOTHELL, WA 98021

188 E. BLAINE STREET, SUITE 127, SEATTLE, WA 98102

Phone Numbers

(206) 492-5722

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$109,997,327.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-03-06 
$42,414,174.00 
$84,828,349.00 
$42,414,175.00 
Equity 
2
2022-11-10 
$22,000,002.00 
$26,000,004.00 
$4,000,002.00 
Equity 
1
2021-12-29 
$45,583,151.00 
$70,583,151.00 
$25,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BAEKSIK 
 
BAE 
DIRECTOR
CUREVO, INC.
MARIO 
 
BARRO 
DIRECTOR
CUREVO, INC.   |  VAXESS TECHNOLOGIES, INC.   |  ILIAD BIOTECHNOLOGIES, INC.
JULIE 
 
BROOKS 
EXECUTIVE OFFICER
VERACYTE, INC.   |  CUREVO, INC.
JAE UK 
 
JEONG 
DIRECTOR
CUREVO, INC.
GIOVANNI 
 
MARIGGI 
DIRECTOR
CUREVO, INC.   |  FORE US BIO INC.   |  ILLEXCOR THERAPEUTICS, INC.
CHARLES 
 
PETTY 
DIRECTOR
FONKOZE USA, INC.   |  CUREVO, INC.
GEORGE 
 
SIMEON 
EXECUTIVE OFFICER, DIRECTOR
CUREVO, INC.
MONCEF 
 
SLAOUI 
DIRECTOR
SUTROVAX, INC.   |  ARTIZAN BIOSCIENCES, INC.   |  ALTESA BIOSCIENCES, INC.   |  ZEPHYR AI, INC.   |  CUREVO, INC.
TAL 
 
ZAKS 
DIRECTOR
CONVERGENT THERAPEUTICS, INC.   |  CUREVO, INC.   |  AVERNA THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-03-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-03-06 
2022-11-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-10 
2022-01-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#